Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Radiosensitivity of human cell lines to small doses. Are there some clinical implications?

Journal Article · · Radiation Research
DOI:https://doi.org/10.2307/3578754· OSTI ID:56760
 [1]; ;  [2]
  1. Institut Gustave-Roussy, Villejuif (France)
  2. Mount Vernon Hospital, Middlesex (United Kingdom)
The concept of intrinsic radiosensitivity is now strongly associated with the linear-quadratic (LQ) model which is currently the best and the most reliable method to fit the first three decades of a survival curve for both human fibroblast and human tumor cell lines. This approach has led to the major conclusions that it is the initial part, and not the distal part, of the survival curve which truly characterizes intrinsic cellular radiosensitivity and there is a correlation between the parameters describing mainly the initial part of the survival curve ({alpha}, SF{sub 2} {bar D}) and the clinical radioresponsiveness. More accurate analysis with flow cytometry or a dynamic microscopic image processing scanner (DMIPS) has allowed further study of the survival curve which has shown two sorts of substructure. On one hand, the overall survival curve of exponentially growing cells is described by two or more sets of {alpha}, {beta} parameters (heterogeneity in radiosensitivity due to the cell cycle). On the other hand, hypersensitivity at very low doses (<0.5 Gy) followed by an increase of the radioresistance of the whole population at higher doses has also been observed. This phenomenon is not described by the conventional LQ model and has been interpreted as an induced radioresistance which seems to be negatively correlated with intrinsic radiosensitivity. In clinical radiotherapy, there are two sorts of response of normal tissues: (1) the early and late damage and (2) the carcinogenesis. Concerning the first point, the clinically detectable radiation damage appears at doses usually around 20 Gy (in 2-Gy fractions) with the exception of the hemopoietic and the lymphatic tissues. Therefore, the small doses delivered at the edges or in the penumbrae of treatment fields in routine radiotherapy cannot create detectable damage, despite a potentially much higher effect per unit dose, because the total doses are still very small. 17 refs.
Sponsoring Organization:
USDOE
OSTI ID:
56760
Report Number(s):
CONF-9305202--
Journal Information:
Radiation Research, Journal Name: Radiation Research Journal Issue: 1 Vol. 138; ISSN 0033-7587; ISSN RAREAE
Country of Publication:
United States
Language:
English